Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
132,169,576
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
91,496,818
-
Shares change
-
+63,807,287
-
Total reported value, excl. options
-
$145,426,221
-
Value change
-
+$101,430,257
-
Number of buys
-
48
-
Number of sells
-
-29
-
Price
-
$1.59
Significant Holders of FRACTYL HEALTH, INC. - Class A Common Stock (GUTS) as of Q3 2025
90 filings reported holding GUTS - FRACTYL HEALTH, INC. - Class A Common Stock as of Q3 2025.
FRACTYL HEALTH, INC. - Class A Common Stock (GUTS) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91,496,818 shares
of 132,169,576 outstanding shares and own 69% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (12,136,917 shares), SILVERARC CAPITAL MANAGEMENT, LLC (10,600,000 shares), Alyeska Investment Group, L.P. (5,648,371 shares), Woodline Partners LP (5,506,534 shares), Catalio Capital Management, LP (5,214,236 shares), Rosalind Advisors, Inc. (5,000,000 shares), General Catalyst Group Management, LLC (4,884,193 shares), Deer Management Co. LLC (4,770,901 shares), HCC Manager LLC (4,673,871 shares), and 683 Capital Management, LLC (4,650,000 shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.